Oncology specialist BeiGene has its Chinese manufacturing operations on lock. With momentum building, the company is turning its gaze to the U.S. with plans to stand up its first factory stateside.

$800 million investment in New Jersey supports global growth and expansion with technologically advanced manufacturing capacity and clinical development capabilities for novel cancer medicines BeiGene ...

Biopharmaceutical manufacturer BeiGene signaled it may be among the first companies applying for state funding under a lucrative state incentive program, as the company unveils plans to expand into ...

“This site is going to help us develop and bring medicines to millions and millions more patients,” BeiGene co-founder, Chairman and CEO John Oyler enthused during the global oncology company’s recent ...

Chinese drugmaker BeiGene has opened a manufacturing plant that it refers to as its Guangzhou base in the city in the northwest of Hong Kong. (Ababsolutum/iStock ...